Gregory D. Brown

Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-Dependent tumor necrosis factor-α antagonists

Matthew E. Voss, Percy H. Carter, Andrew J. Tebben et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 69 citations · Full text

Inflammation, Molecular Pharmacology, Medicinal Chemistry +7

Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase

Reema K. Thalji, J. Jeffrey McAtee, Svetlana Belyanskaya et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 64 citations · Full text

Soluble Epoxide Hydrolase, Medicinal Chemistry, Biochemistry +5

BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate

Robert J. Cherney, Prakash Anjanappa, K. Selvakumar et al. · ACS Medicinal Chemistry Letters · 2021 · 39 citations · Full text

Tetrahydro-4-quinolinamines identified as novel P2Y1 receptor antagonists

Ángel I. Morales-Ramos, John S. Mecom, Terry J. Kiesow et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 33 citations · Full text

Biochemistry, Functional Selectivity, Medicine +5

Discovery of pyrrolo[1,2-b]pyridazine-3-carboxamides as Janus kinase (JAK) inhibitors

James J.‐W. Duan, Zhonghui Lu, Bin Jiang et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 30 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +8